ClinVar Miner

Submissions for variant NM_175614.5(NDUFA11):c.138G>A (p.Pro46=)

gnomAD frequency: 0.00029  dbSNP: rs138889960
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000914175 SCV000251770 likely benign not provided 2021-04-13 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000382120 SCV000414847 uncertain significance Mitochondrial complex I deficiency, nuclear type 1 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Invitae RCV000914175 SCV001059339 likely benign not provided 2023-12-21 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000914175 SCV002498405 likely benign not provided 2022-03-01 criteria provided, single submitter clinical testing NDUFA11: BP4, BP7
PreventionGenetics, part of Exact Sciences RCV003947634 SCV004762303 likely benign NDUFA11-related condition 2022-07-06 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000914175 SCV001552774 uncertain significance not provided no assertion criteria provided clinical testing The NDUFA11 p.Pro46Pro variant was not identified in the literature nor was it identified in Cosmic and LOVD 3.0 databases. The variant was identified in dbSNP (ID: rs138889960) as “With Uncertain significance allele” and in ClinVar (conflicting interpretations of pathogenicity: likely benign by GeneDx and uncertain significance by Illumina Clinical Services Laboratory; associated phenotype of Mitochondrial complex I deficiency). The variant was identified in control databases in 137 of 282780 chromosomes (1 homozygous) at a frequency of 0.000484 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Latino in 49 of 35432 chromosomes (freq: 0.001383), Other in 9 of 7226 chromosomes (freq: 0.001246), South Asian in 15 of 30616 chromosomes (freq: 0.00049), European (non-Finnish) in 60 of 129174 chromosomes (freq: 0.000465), African in 3 of 24960 chromosomes (freq: 0.00012), East Asian in 1 of 19952 chromosomes (freq: 0.00005), while the variant was not observed in the Ashkenazi Jewish, European (Finnish), populations. The p.Pro46Pro variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. The variant occurs outside of the splicing consensus sequence and 3 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, and GeneSplicer) predict a greater than 10% difference in splicing (creation of a 3’ splice site at c.139). However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.